| igama lomkhiqizo | Inombolo ye-athikili | Izingcaphuno | Izixhumanisi zemibhalo |
| Igama lomkhiqizo: Recombinant HumanbFGFProtein | Inombolo ye-athikili: GMP-TL901 | I-GNPNAT1 ithuthukisa ukuqina komdlavuza webele futhi isebenza njenge-biomarker enamandla yokubikezela | https://www.spandidos-publications.com/10.3892/or.2023.8594 |
| Igama lomkhiqizo: I-Recombinant HumanEGFProtein | Inombolo ye-athikili: GMP-TL613 | I-GNPNAT1 ithuthukisa ukuqina komdlavuza webele futhi isebenza njenge-biomarker enamandla yokubikezela | https://www.spandidos-publications.com/10.3892/or.2023.8594 |
| igama lomkhiqizo: AMMS®MSC Cell Culture Kit 2.0 | Inombolo ye-athikili: AS-13 | Izakhiwo Zengqamuzana Ezithuthukisiwe Zamangqamuzana Esiqu Samazinyo Omuntu (ama-hDPSC) Ahlukanisiwe futhi Anwetshwa Ngokuthobelana ne-GMP kanye ne-Xenogeneic Serum-free Medium | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621445/ |
| Igama lomkhiqizo: Recombinant HumanIL-7Protein | Inombolo ye-athikili: GMP-TL506 | I-TGFβ receptor II enamandla kakhulu ne-TIM3 encishisiwe ithuthukisa ukusebenza kahle kwe-antitumor ye-CAR-T-cell therapy kumdlavuza wendlala yesinye. | https://www.sciencedirect.com/science/article/pii/S1567576923011323 |
| Igama lomkhiqizo: Recombinant HumanIL-15Protein | Inombolo ye-athikili: GMP-TL202 | I-TGFβ receptor II enamandla kakhulu ne-TIM3 encishisiwe ithuthukisa ukusebenza kahle kwe-antitumor ye-CAR-T-cell therapy kumdlavuza wendlala yesinye. | https://www.sciencedirect.com/science/article/pii/S1567576923011323 |
| Igama lomkhiqizo: Recombinant HumanIL-21Protein | Inombolo ye-athikili: GMP-TL509 | I-TGFβ receptor II enamandla kakhulu ne-TIM3 encishisiwe ithuthukisa ukusebenza kahle kwe-antitumor ye-CAR-T-cell therapy kumdlavuza wendlala yesinye. | https://www.sciencedirect.com/science/article/pii/S1567576923011323 |
| Igama lomkhiqizo: Anti-humanCD3mAb | Inombolo ye-athikili: GMP-TL101 | I-TGFβ receptor II enamandla kakhulu ne-TIM3 encishisiwe ithuthukisa ukusebenza kahle kwe-antitumor ye-CAR-T-cell therapy kumdlavuza wendlala yesinye. | https://www.sciencedirect.com/science/article/pii/S1567576923011323 |
| Igama lomkhiqizo: Anti-humanCD28mAb | Inombolo ye-athikili: GMP-TL102 | I-TGFβ receptor II enamandla kakhulu ne-TIM3 encishisiwe ithuthukisa ukusebenza kahle kwe-antitumor ye-CAR-T-cell therapy kumdlavuza wendlala yesinye. | https://www.sciencedirect.com/science/article/pii/S1567576923011323 |
| Igama lomkhiqizo: AMMS®NK cell culture kit | | Amaseli e-Bicistronic CAR-T aqondise i-CD123 ne-CLL1 ye-AML ukuze anciphise ubungozi bokuphunyuka kwe-antigen | https://www.sciencedirect.com/science/article/pii/S1936523323000815 |
| Igama lomkhiqizo: I-Recombinant HumanIFN-γProtein | Inombolo ye-athikili: GMP-TL105 | I-miR-1187 idala ukulimala kwe-podocyte kanye ne-nephropathy yesifo sikashukela ngokusebenzisa i-autophagy | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201642/ |
| Igama lomkhiqizo: Recombinant HumanIL-2Protein | Inombolo ye-athikili: GMP-TL906 | I-DOI: 10.3969/j.issn.1671-2587.2023.03.006 | http://www.lcsxyjy.com/CN/Y2023/V25/I3/320 |
| Igama lomkhiqizo: Anti-humanCD3mAb | Inombolo ye-athikili: GMP-TL101 | I-DOI: 10.3969/j.issn.1671-2587.2023.03.006 | http://www.lcsxyjy.com/CN/Y2023/V25/I3/320 |
| Igama lomkhiqizo: Anti-humanCD3mAb | Inombolo ye-athikili: GMP-TL101 | Amaseli e-CAR-T aqondiswe ku-B7-H3 abonisa ukusebenza kahle kakhulu kwe-anti-tumor ngokumelene ne-osteosarcoma kokubili ku-vitro kanye ne-vivo | https://bmccancer.biomedcentral.com/articles/10.1186/s12885-022-10229-8 |
| Igama lomkhiqizo: Anti-humanCD28mAb | Inombolo ye-athikili: GMP-TL102 | Amaseli e-CAR-T aqondiswe ku-B7-H3 abonisa ukusebenza kahle kakhulu kwe-anti-tumor ngokumelene ne-osteosarcoma kokubili ku-vitro kanye ne-vivo | https://bmccancer.biomedcentral.com/articles/10.1186/s12885-022-10229-8 |
| Igama lomkhiqizo: Anti-humanCD3mAb | Inombolo ye-athikili: GMP-TL101 | I-Romidepsin Ithuthukisa Amandla Okubulala Amaseli e-NKG2D-CAR-T Ngokuvezwa Okuthuthukisiwe kwe-NKG2DL ngokumelene namaseli omdlavuza we-Ovarian | https://www.imrpress.com/journal/CEOG/49/10/10.31083/j.ceog4910227/htm |
| Igama lomkhiqizo: I-Recombinant HumanIFN-γProtein | Inombolo ye-athikili: GMP-TL105 | I-Complanatuside inciphisa ukulimala kwamangqamuzana okuvuvukala okubangelwa ama-cytokines avuvukalayo kuma-keratinocyte esikhumba. | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399639/ |
| Igama lomkhiqizo: Recombinant HumanIL-5Protein | Inombolo ye-athikili: GMP-TL754 | I-DOI:10.27272/d.cnki.gshdu.2022.000433. | https://www.zhangqiaokeyan.com/academic-degree-domestic_mphd_thesis/020315252241.html |
| Igama lomkhiqizo: I-Recombinant HumanIL-1βProtein | Inombolo ye-athikili: GMP-TL513 | I-DOI:10.27272/d.cnki.gshdu.2022.000433. | https://www.zhangqiaokeyan.com/academic-degree-domestic_mphd_thesis/020315252241.html |
| Igama lomkhiqizo: I-Recombinant HumanIFN-γProtein | Inombolo ye-athikili: GMP-TL105 | I-Piperazine-based Mitochondria-Immobilized pH Fluorescent Probe ye-Imaging Endogenous ONOO– kanye Nokulandelela Isikhathi Sangempela Kwe-Mitophagy | https://pubs.acs.org/doi/abs/10.1021/acsabm.2c00213 |
| Igama lomkhiqizo: I-Recombinant HumanGM-CSFProtein | Inombolo ye-athikili: GMP-TL302 | I-DOI:10.27170/d.cnki.gjsuu.2022.000908. | https://cdmd.cnki.com.cn/Article/CDMD-10299-1022583126.htm |
| Igama lomkhiqizo: Recombinant HumanIL-4Protein | Inombolo ye-athikili: GMP-TL301 | I-DOI:10.27170/d.cnki.gjsuu.2022.000908. | https://cdmd.cnki.com.cn/Article/CDMD-10299-1022583126.htm |
| Igama lomkhiqizo: Recombinant HumanIL-2Protein | Inombolo ye-athikili: GMP-TL906 | doi: 10. 13303 /j. cjbt. issn. 1004-549x. 2022. 08. 010 | https://www.nstl.gov.cn/paper_detail.html?id=5638a20c5237a010b325feea8836a6eb |
| Igama lomkhiqizo: Anti-humanCD3mAb | Inombolo ye-athikili: GMP-TL101 | doi: 10. 13303 /j. cjbt. issn. 1004-549x. 2022. 08. 010 | https://www.nstl.gov.cn/paper_detail.html?id=5638a20c5237a010b325feea8836a6eb |
| Igama lomkhiqizo: Recombinant HumanIL-2Protein | Inombolo ye-athikili: GMP-TL906 | I-DOI:10.26998/d.cnki.gjuyu.2022.000131. | https://d.wanfangdata.com.cn/thesis/D02790739 |
| Igama lomkhiqizo: Anti-humanCD3mAb | Inombolo ye-athikili: GMP-TL101 | I-DOI:10.26998/d.cnki.gjuyu.2022.000131. | https://d.wanfangdata.com.cn/thesis/D02790739 |
| Igama lomkhiqizo: Anti-humanCD28mAb | Inombolo ye-athikili: GMP-TL102 | I-DOI:10.26998/d.cnki.gjuyu.2022.000131. | https://d.wanfangdata.com.cn/thesis/D02790739 |
| Igama lomkhiqizo: Recombinant HumanIL-2Protein | Inombolo ye-athikili: GMP-TL906 | I-DOI:10.27262/d.cnki.gqdau.2022.000392. | https://d.wanfangdata.com.cn/thesis/D02865862 |
| Igama lomkhiqizo: I-Recombinant HumanIL-12Protein | Inombolo ye-athikili: GMP-TL508 | I-DOI:10.27262/d.cnki.gqdau.2022.000392. | https://d.wanfangdata.com.cn/thesis/D02865862 |
| Igama lomkhiqizo: Recombinant HumanIL-15Protein | Inombolo ye-athikili: GMP-TL202 | I-DOI:10.27262/d.cnki.gqdau.2022.000392. | https://d.wanfangdata.com.cn/thesis/D02865862 |
| Igama lomkhiqizo: Recombinant HumanIL-21Protein | Inombolo ye-athikili: GMP-TL509 | I-DOI:10.27262/d.cnki.gqdau.2022.000392. | https://d.wanfangdata.com.cn/thesis/D02865862 |
| Igama lomkhiqizo: Anti-humanCD16mAb | Inombolo ye-athikili: GMP-TL201 | I-DOI:10.27262/d.cnki.gqdau.2022.000392. | https://d.wanfangdata.com.cn/thesis/D02865862 |
| Igama lomkhiqizo: I-Recombinant HumanBMP-2Protein | Inombolo ye-athikili: GMP-TL634 | I-DOI:10.27232/d.cnki.gnchu.2022.000372. | https://cdmd.cnki.com.cn/Article/CDMD-10403-1022637642.htm |
| Igama lomkhiqizo: Recombinant HumanPDGF-BBProtein | Inombolo ye-athikili: GMP-TL644 | I-DOI:10.27232/d.cnki.gnchu.2022.000372. | https://cdmd.cnki.com.cn/Article/CDMD-10403-1022637642.htm |
| Igama lomkhiqizo: Anti-humanCD3mAb | Inombolo ye-athikili: GMP-TL101 | I-Liraglutide yenza kusebenze impendulo ye-antitumor ebulalayo yemvelo ngokuvimbela ukusayina kwe-IL-6/STAT3 ku-hepatocellular carcinoma, | https://www.sciencedirect.com/science/article/pii/S1936523320303648 |
| Igama lomkhiqizo: Anti-humanCD3mAb | Inombolo ye-athikili: GMP-TL101 | 10.27038/d.cnki.ggxyu.2021.000719. | https://wap.cnki.net/touch/web/Dissertation/Article/1022009152.nh.html |
| Igama lomkhiqizo: Anti-humanCD28mAb | Inombolo ye-athikili: GMP-TL102 | 10.27038/d.cnki.ggxyu.2021.000719. | https://wap.cnki.net/touch/web/Dissertation/Article/1022009152.nh.html |
| Igama lomkhiqizo: I-Recombinant HumanHER2Protein | Inombolo ye-athikili: GMP-TL734 | I-DOI:10.27169/d.cnki.gwqgu.2021.001008. | http://cdmd.cnki.com.cn/Article/CDMD-10295-1021757302.htm |
| Igama lomkhiqizo: Recombinant HumanIL-2Protein | Inombolo ye-athikili: GMP-TL906 | I-DOI:10.27648/d.cnki.gzxhu.2021.000589 | https://cdmd.cnki.com.cn/Article/CDMD-10023-1021169654.htm |
| Igama lomkhiqizo: Anti-humanCD28mAb | Inombolo ye-athikili: GMP-TL102 | I-DOI:10.27819/d.cnki.gzgjl.2021.000573. | https://read.cnki.net/web/Dissertation/Article/10356-1021159713.nh.html |
| Igama lomkhiqizo: I-Recombinant HumanSCFProtein | Inombolo ye-athikili: GMP-TL504 | I-DOI:10.27466/d.cnki.gzzdu.2021.001720. | https://d.wanfangdata.com.cn/thesis/Y3844118 |
| Igama lomkhiqizo: Anti-humanCD3mAb | Inombolo ye-athikili: GMP-TL101 | Ukwandiswa kwamaLymphocyte Angena Ngesimila (TILs) anezakhiwo eziqinile ze-Stemness ezivela ku-Vulvar Cancer | https://www.gavinpublishers.com/article/view/expansion-of-tumor-infiltrating-lymphocytes--tils-with-substantial-stemness-properties--from-vulvar-cancer |
| Igama lomkhiqizo: Recombinant HumanIL-2Protein | Inombolo ye-athikili: GMP-TL906 | Ukwandiswa kwamaLymphocyte Angena Ngesimila (TILs) anezakhiwo eziqinile ze-Stemness ezivela ku-Vulvar Cancer | https://www.gavinpublishers.com/article/view/expansion-of-tumor-infiltrating-lymphocytes--tils-with-substantial-stemness-properties--from-vulvar-cancer |
